BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21863287)

  • 21. Variant of ETV6/ABL1 gene is associated with leukemia phenotype.
    Park J; Kim M; Lim J; Kim Y; Han K; Kim JS; Lee S; Kim HJ; Min WS
    Acta Haematol; 2013; 129(2):78-82. PubMed ID: 23171811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABL1 fusion genes in hematological malignancies: a review.
    De Braekeleer E; Douet-Guilbert N; Rowe D; Bown N; Morel F; Berthou C; Férec C; De Braekeleer M
    Eur J Haematol; 2011 May; 86(5):361-71. PubMed ID: 21435002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.
    Soler G; Radford-Weiss I; Ben-Abdelali R; Mahlaoui N; Ponceau JF; Macintyre EA; Vekemans M; Bernard OA; Romana SP
    Leukemia; 2008 Jun; 22(6):1278-80. PubMed ID: 18007576
    [No Abstract]   [Full Text] [Related]  

  • 25. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
    Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
    Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of a cryptic
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of the SEPT9-ABL1 chimeric fusion gene derived from T-prolymphocytic leukemia.
    Kawai H; Matsushita H; Suzuki R; Sheng Y; Lu J; Matsuzawa H; Yahata T; Tsuma-Kaneko M; Tsukamoto H; Kawada H; Ogawa Y; Ando K
    Leuk Res; 2014 Dec; 38(12):1451-9. PubMed ID: 25217890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors.
    Xie W; Wang SA; Hu S; Xu J; Medeiros LJ; Tang G
    Cancer Genet; 2018 Dec; 228-229():41-46. PubMed ID: 30553471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
    Sheng G; Zeng Z; Pan J; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Acta Haematol; 2017; 137(1):40-43. PubMed ID: 27894117
    [No Abstract]   [Full Text] [Related]  

  • 31. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.
    Graux C; Cools J; Melotte C; Quentmeier H; Ferrando A; Levine R; Vermeesch JR; Stul M; Dutta B; Boeckx N; Bosly A; Heimann P; Uyttebroeck A; Mentens N; Somers R; MacLeod RA; Drexler HG; Look AT; Gilliland DG; Michaux L; Vandenberghe P; Wlodarska I; Marynen P; Hagemeijer A
    Nat Genet; 2004 Oct; 36(10):1084-9. PubMed ID: 15361874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.
    Van Limbergen H; Beverloo HB; van Drunen E; Janssens A; Hählen K; Poppe B; Van Roy N; Marynen P; De Paepe A; Slater R; Speleman F
    Genes Chromosomes Cancer; 2001 Mar; 30(3):274-82. PubMed ID: 11170285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A t(1;9)(q23.3 approximately q25;q34) affecting the ABL1 gene in a biphenotypic leukemia.
    González García JR; Bohlander SK; Gutiérrez Angulo M; Esparza Flores MA; Picos Cárdenas VJ; Meza Espinoza JP; Ayala Madrigal Mde L; Rivera H
    Cancer Genet Cytogenet; 2004 Jul; 152(1):81-3. PubMed ID: 15193448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of leukemias with ETV6-ABL1 fusion.
    Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
    Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.
    Raca G; Gurbuxani S; Zhang Z; Li Z; Sukhanova M; McNeer J; Stock W
    Leuk Lymphoma; 2015 Apr; 56(4):1145-7. PubMed ID: 25098428
    [No Abstract]   [Full Text] [Related]  

  • 36. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia.
    Griesinger F; Hennig H; Hillmer F; Podleschny M; Steffens R; Pies A; Wörmann B; Haase D; Bohlander SK
    Genes Chromosomes Cancer; 2005 Nov; 44(3):329-33. PubMed ID: 16001431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy.
    Yeh CH; Abdool A; Bruey JM
    Cancer Biomark; 2010; 7(6):295-303. PubMed ID: 21694468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Zimmermannova O; Doktorova E; Stuchly J; Kanderova V; Kuzilkova D; Strnad H; Starkova J; Alberich-Jorda M; Falkenburg JHF; Trka J; Petrak J; Zuna J; Zaliova M
    Oncogene; 2017 Oct; 36(43):5985-5994. PubMed ID: 28650474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study.
    Sadia H; Siddiqui RT; Nasim A
    Cancer Genet Cytogenet; 2010 Aug; 201(1):57-61. PubMed ID: 20633771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
    Boer JM; den Boer ML
    Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.